Progyny (PGNY) Cash & Current Investments (2018 - 2026)

Progyny (PGNY) has reported Cash & Current Investments for 9 consecutive years, with $225.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash & Current Investments fell 12.11% year-over-year to $225.1 million; the TTM figure through Mar 2026 stood at $225.1 million (down 12.11% YoY), while the FY2025 annual figure was $310.1 million, up 36.03% from the prior year.
• Cash & Current Investments declined to $225.1 million in Q1 2026 per PGNY's latest filing, from $310.1 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $371.8 million in Q1 2024 and bottomed at $105.7 million in Q1 2022.
• Historically, Cash & Current Investments has averaged $252.6 million across 5 years, with a median of $256.1 million in 2025.
• Annual changes were most pronounced in 2023 — Cash & Current Investments jumped 137.99% — and 2024, when it plunged 38.57%.
• Progyny's Cash & Current Investments stood at $189.3 million in 2022, then surged by 96.03% to $371.1 million in 2023, then slumped by 38.57% to $228.0 million in 2024, then soared by 36.03% to $310.1 million in 2025, then slipped by 27.41% to $225.1 million in 2026.
• Business Quant data shows PGNY's Cash & Current Investments at $225.1 million in Q1 2026, $310.1 million in Q4 2025, and $345.2 million in Q3 2025.